Dr. Michael Andrew Ahdoot, MD

Dr. Ahdoot practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Ahdoot's NPI, 1255775912, was assigned on April 24, 2013. Dr. Ahdoot graduated from Stanford University School Of Medicine in 2012. Dr. Ahdoot's California license number on file is A167281.

Dr. Ahdoot's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Ahdoot's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Ahdoot to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ahdoot practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ahdoot's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Ahdoot is board certified in urology by the American Board of Urology. Dmand AI has Dr. Ahdoot's licenses on file in 3 states: California, Montana and District of Columbia.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, kidney stone disease, prostate cancer and prostate surgery among the conditions Dr. Ahdoot treats.

CMS data shows 593 Medicare services from Dr. Ahdoot across 12 procedure codes in 2024, for 186 Medicare patients. Medicare paid $42,248 for them.

CMS counts 186 Medicare patients who saw Dr. Ahdoot in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ahdoot's median patient age at 71, with 22% women.

In 2024, Dr. Ahdoot wrote 378 Medicare Part D claims for 108 patients. 81% of them were for generic drugs. CMS names the drug for 317 of them, across 8 drugs with 11 or more claims each, at $71,461 in total drug cost. In 2023, CMS named 275 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Ahdoot for performance year 2024, reported as part of a group. Dr. Ahdoot accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ahdoot as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Ahdoot, published from 2014 to 2020. Dr. Ahdoot's most frequent co-authors are Sandeep Gurram, MD, Amir Hossein Lebastchi, MD and Peter Anthony Pinto, MD.

CMS Open Payments shows 94 general payments to Dr. Ahdoot from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Edap Technomed Inc paid the most, $9,186.

Dr. Ahdoot graduated from Stanford University School Of Medicine in 2012.

Dr. Ahdoot is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.